EULAR takes ‘precautionary position’ in support of third, booster COVID-19 vaccine doses

Citing a lack of available data and time, EULAR has taken a “precautionary position” in support of third and booster COVID-19 vaccine doses for patients with rheumatic and musculoskeletal diseases.
“There are concerns that individuals on certain immunosuppressive or immunomodulatory drugs may not mount an adequate protective response to COVID-19 vaccination,” Robert B.M. Landewé, MD, PhD, of Amsterdam UMC, and colleagues wrote in the Annals of the Rheumatic Diseases. “Data are not currently available to reliably identify who might, or might not, benefit

Citing a lack of available data and time, EULAR has taken a “precautionary position” in support of third and booster COVID-19 vaccine doses for patients with rheumatic and musculoskeletal diseases.
“There are concerns that individuals on certain immunosuppressive or immunomodulatory drugs may not mount an adequate protective response to COVID-19 vaccination,” Robert B.M. Landewé, MD, PhD, of Amsterdam UMC, and colleagues wrote in the Annals of the Rheumatic Diseases. “Data are not currently available to reliably identify who might, or might not, benefit